Cardiovascular Tablets Manufacturer India

What We Manufacture

Our Cardiovascular Drugs tablet range

Our cardiovascular tablet range covers the essential hypertension, dyslipidemia and cardiac arrhythmia molecules — among the most chronically prescribed drug categories globally, with sustained demand across government health programmes and retail pharmacy.

Antihypertensives

Calcium channel blockers, ACE inhibitors and ARBs for management of hypertension and heart failure.

Amlodipine 2.5mg · 5mg · 10mg Tablet
Ramipril 1.25mg · 2.5mg · 5mg · 10mg Tablet
Telmisartan 20mg · 40mg · 80mg Tablet
Losartan 25mg · 50mg · 100mg Tablet
Enalapril 2.5mg · 5mg · 10mg · 20mg Tablet

Beta-Blockers

Beta-adrenergic blockers for hypertension, angina, heart failure and arrhythmia management.

Metoprolol Succinate 25mg · 50mg · 100mg (ER) Tablet
Atenolol 25mg · 50mg · 100mg Tablet
Carvedilol 3.125mg · 6.25mg · 12.5mg · 25mg Tablet

Lipid-Lowering Agents

Statins and combination lipid-lowering agents for dyslipidemia management and cardiovascular risk reduction.

Atorvastatin 10mg · 20mg · 40mg · 80mg Tablet
Rosuvastatin 5mg · 10mg · 20mg · 40mg Tablet
Atorvastatin + Ezetimibe combination tablet

Diuretics

Loop and thiazide diuretics for hypertension, oedema and heart failure management.

Furosemide 20mg · 40mg · 80mg Tablet
Hydrochlorothiazide 12.5mg · 25mg Tablet
Spironolactone 25mg · 50mg · 100mg Tablet

Available Tablet Types

Standard tablets — compressed, film-coated
Enteric-coated tablets — delayed release
Extended-release tablets — controlled delivery
Dispersible tablets — dissolves in water
Alu-Alu cold form blister · Alu-PVC blister · Strip packing

Enquire Now

Why 9M India

Cardiovascular tablet manufacturing for long-term supply reliability

WHO-GMP certified solid dosage manufacturing

Cardiovascular tablets are chronically prescribed — patients take them daily for years or decades. This makes supply reliability and batch-to-batch consistency critical beyond what most acute-use drug categories demand. 9M India's WHO-GMP certified facility with 177 million unit annual capacity and validated manufacturing processes ensures consistent cardiovascular tablet supply for institutional programmes and export buyers.
In-house QC — every batch tested before dispatch

Dissolution testing · Disintegration · Hardness · Friability · Assay (HPLC) · Content uniformity · Related substances · Microbiological limits — all tested in our in-house analytical laboratory. Certificate of Analysis issued from our own facility.
Documentation ready for government tenders and export

Manufacturing Licence · DCGI product approvals · WHO-GMP Certificate · COA · COC · Stability data (ICH aligned) — pre-prepared and available within 24 hours for tender submission, export registration or CDMO due diligence.

Who We Supply

Who sources cardiovascular tablets from 9M India

Government & institutional buyers

State NHM hypertension and cardiovascular disease programmes, CGHS empanelment, ESIC supply — cardiovascular tablets are the second-largest tablet category in government pharmaceutical tenders after antibiotics.
Domestic pharma brands (3PM/Private Label)

Domestic pharma brands manufacturing cardiovascular tablets through 9M India — complete private label manufacturing with WHO-GMP documentation, DCGI approvals and batch-level COA.
International export buyers

Middle Eastern, East African and South-East Asian buyers — lifestyle disease burden is rising rapidly in all export markets, driving sustained demand growth for cardiovascular generics.